Skip to main contentSkip to navigation
Sirius Investors

DNA Brands, Inc. (DNAX) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate DNA Brands, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2024
P/E Ratio
-1.00
Burn Risk
P/B Ratio
-0.11
Equity Deficit
Earnings Yield
-99.03%
Yield Gap

Profitability Health

2024
Return on Equity
10.69%
Moderate
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data

Growth Indicators

2024
Revenue Growth
-
No data
Net Income Growth
25.60%
Strong
WeakModerateStrong
EPS Growth
80.00%
Strong
WeakModerateStrong

Efficiency & Liquidity

2024
Current Ratio
0.01
Weak
WeakModerateStrong
Quick Ratio
0.01
Weak
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2024
Free Cash Flow Yield
-2.28%
Weak
WeakModerateStrong
EV / Free Cash Flow
-297.95x
Strong
WeakModerateStrong
Net Debt / EBITDA
-12.24x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
2.092
Strong
WeakModerateStrong
Return on Invested Capital
13.64%
Weak
WeakModerateStrong
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for DNAX.

View Financial Statements